(Q60705943)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3533565%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

title

Steady-state concentrations of imipramine and its metabolites in relation to the sparteine/debrisoquine polymorphism (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3533565%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3533565%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

R Klysner

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3533565%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

L F Gram

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3533565%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

S V Otton

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3533565%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

P Bech

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3533565%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

L Bertilsson

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3533565%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

publication date

1 January 1986

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3533565%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Clinical Pharmacology

28 September 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3533565%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3533565%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3533565%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

page(s)

679-684

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3533565%20AND%20SRC:MED&resulttype=core&format=json

A family study of genetic and environmental factors determining polymorphic hydroxylation of debrisoquin

28 September 2019

cites work

1 reference

12 December 2020

Polymorphic oxidation of sparteine and debrisoquine: Related pharmacogenetic entities

1 reference

12 December 2020

The debrisoquine hydroxylation test predicts steady-state plasma levels of desipramine

1 reference

12 December 2020

Sparteine metabolism in Canadian Caucasians

1 reference

12 December 2020

Clinical implications of imipramine plasma levels for depressive illness

1 reference

12 December 2020

Sparteine oxidation polymorphism: a family study

1 reference

12 December 2020

Phenotypic consistency in hydroxylation of desmethylimipramine and debrisoquine in healthy subjects and in human liver microsomes

1 reference

12 December 2020

E- and Z-10-hydroxylation of nortriptyline: relationship to polymorphic debrisoquine hydroxylation

1 reference

12 December 2020

Dose-dependent kinetics of imipramine in elderly patients

1 reference

12 December 2020

Plasma concentrations of nortriptyline and its 10-hydroxy metabolite in depressed patients--relationship to the debrisoquine hydroxylation metabolic ratio

1 reference

12 December 2020

Sparteine oxidation polymorphism in Denmark

1 reference

12 December 2020

Steady-state kinetics of imipramine in patients

1 reference

12 December 2020

Imipramine: Clinical effects and pharmacokinetic variability

1 reference

12 December 2020

Nortriptyline and debrisoquine hydroxylations in Ghanaian and Swedish subjects.

1 reference

12 December 2020

Imipramine metabolites in blood of patients during therapy and after overdose

1 reference

12 December 2020

A family and population study of the genetic polymorphism of debrisoquine oxidation in a white British population.

1 reference

12 December 2020

Comparative pharmacogenetics of sparteine and debrisoquine

1 reference

12 December 2020

Amitriptyline metabolism: association with debrisoquin hydroxylation in nonsmokers

1 reference

12 December 2020

Effects of perphenazine on imipramine metabolism in man

1 reference

12 December 2020

Characterization of a human liver cytochrome P-450 involved in the oxidation of debrisoquine and other drugs by using antibodies raised to the analogous rat enzyme

1 reference

12 December 2020

Determination of debrisoquine and its 4-hydroxy metabolite in biological fluids by gas chromatography with flame-ionization and nitrogen-selective detection

1 reference

12 December 2020

Role of oxidation polymorphism on blood and urine concentrations of amitriptyline and its metabolites in man

1 reference

12 December 2020

Metabolism of tricyclic antidepressants. A review

1 reference

12 December 2020

Amitriptyline metabolism: relationship to polymorphic debrisoquine hydroxylation

1 reference

12 December 2020

Steady-state levels of imipramine and its metabolites: significance of dose-dependent kinetics

1 reference

12 December 2020

The genetic control of sparteine and debrisoquine metabolism in man with new methods of analysing bimodal distributions

1 reference

12 December 2020

Inhibition of sparteine oxidation in human liver by tricyclic antidepressants and other drugs

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00608215

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3533565%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3533565%20AND%20SRC:MED&resulttype=core&format=json